Results for Acute Myeloid Leukemia

Uniting more than 9,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers in the fight against childhood cancer.

The Kurre Laboratory has a longstanding interest in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With expertise in transplantation and hematopoietic stem cell biology, the lab aims to improve the understanding of the progressive hematopoietic failure in patients with BMF and FA, broaden diagnostic approaches, and develop next generation therapies.

Bringing together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies as well as basic research focused on acquired and inherited bone marrow failure.

The Tong laboratory studies cytokine receptor and ubiquitin signaling in hematopoietic stem cells, bone marrow failure, and leukemia.

Research in the Tasian Laboratory focuses on the bench-to-bedside investigation of precision medicine therapies for high-risk childhood leukemias.

The Aplenc Lab investigates ways to improve the outcomes of children with cancer, particularly acute myeloid leukemia, through translational studies, patient-centered outcomes research, and with clinical epidemiology studies.